Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life studyNicola Pugliese, Alessio Aghemo, Alessia Giorgini et al.|Expert Opinion on Drug Safety|2021Cited by 6
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimenVelia Chiara Di Maio, Sergio Babudieri, Carmine Minichini et al.|Digestive and Liver Disease|2020Cited by 1
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experienceVelia Chiara Di Maio, C. Paternoster, M. Aragri et al.|Digestive and Liver Disease|2019Cited by 0
THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experienceVelia Chiara Di Maio, Giustino Parruti, M. Aragri et al.|Journal of Hepatology|2019Cited by 0